345 related articles for article (PubMed ID: 23694806)
1. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
[TBL] [Abstract][Full Text] [Related]
2. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
4. Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers.
Zhao C; Fan T; Yang Y; Wu M; Li L; Zhou Z; Jian Y; Zhang Q; Huang Y
Int J Pharm; 2013 Jun; 450(1-2):11-20. PubMed ID: 23612355
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis.
Huguet-Casquero A; Xu Y; Gainza E; Pedraz JL; Beloqui A
Int J Pharm; 2020 Aug; 586():119515. PubMed ID: 32544520
[TBL] [Abstract][Full Text] [Related]
6. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease.
Beloqui A; Memvanga PB; Coco R; Reimondez-Troitiño S; Alhouayek M; Muccioli GG; Alonso MJ; Csaba N; de la Fuente M; Préat V
Colloids Surf B Biointerfaces; 2016 Jul; 143():327-335. PubMed ID: 27022873
[TBL] [Abstract][Full Text] [Related]
8. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
9. Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease.
Sinhmar GK; Shah NN; Rawal SU; Chokshi NV; Khatri HN; Patel BM; Patel MM
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):565-578. PubMed ID: 29661024
[TBL] [Abstract][Full Text] [Related]
10. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
Sann H; Erichsen Jv; Hessmann M; Pahl A; Hoffmeyer A
Life Sci; 2013 Apr; 92(12):708-18. PubMed ID: 23399699
[TBL] [Abstract][Full Text] [Related]
12. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
13. Glial-derived neurotrophic factor reduces inflammation and improves delayed colonic transit in rat models of dextran sulfate sodium-induced colitis.
Liu GX; Yang YX; Yan J; Zhang T; Zou YP; Huang XL; Gan HT
Int Immunopharmacol; 2014 Mar; 19(1):145-52. PubMed ID: 24462388
[TBL] [Abstract][Full Text] [Related]
14. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis.
Marcon R; Bento AF; Dutra RC; Bicca MA; Leite DF; Calixto JB
J Immunol; 2013 Oct; 191(8):4288-98. PubMed ID: 24038091
[TBL] [Abstract][Full Text] [Related]
15. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
[TBL] [Abstract][Full Text] [Related]
16. Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation.
Varshosaz J; Minaiyan M; Khaleghi N
J Microencapsul; 2015; 32(3):211-23. PubMed ID: 25561026
[TBL] [Abstract][Full Text] [Related]
17. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice.
Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK
J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
19. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y
Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
